Program

Nov. 4th

Session 1
Chairperson: Chengjiang Gao
19:00-19:30 Keynote Lecture —— Regulation of T cell activation and function in cancer Chen Dong
19:30-20:00 CD8+ T Cell Differentiation and Cancer Immunotherapy Lilin Ye
Chairperson: Haopeng Wang
20:00-20:30 Immunological tolerance is maintained by auto-reactive CD8+ T cells Linrong Lu
20:30-21:00 Developing TCR-based chimeric antigen receptor STAR for immunotherapy Xin Lin

Nov. 5th

Chairperson: Feilong Meng
8:30-9:00 Opening ceremony Speeches by President and co-chairs
9:00-9:50 Keynote Lecture —— Crosstalk between innate and adaptive immune systems in cancer immune response and immunotherapy Weiping Zou
Session 2
Chairperson: Zhihua Liu
9:50-10:20 The Role of Antigen-Specific T Cells in Cancer Immunotherapy Feng Wang
Break
10:20-10:40 Imaging cytometry coupled with spectral immunophenotyping enables novel applications and reveals spatial dimensions in receptor expression profiles. Aaron Middlebrook
Chairperson: Leng Siew Yeap
10:40-11:10 Regulating iNKT cells in tumor immunity Li Bai
11:10-11:40 Intrinsic programming and quality control of T cell memory in tumors Meng Michelle Xu
11:40-12:10 Mechanism and intervention strategies of glioblastoma stem cell self-renewal Xiuxing Wang
12:10-12:25 Xinda  
14:00-16:00 Free Discussion  
16:00-17:30 Poster Session  
Session 3
Chairperson: Linrong Lu
19:00-19:30 Structural Modulation of CAR Signalling for Tailored T cell-based Immunotherapies Matthew E Call
19:30-20:00 Understanding T-Cell Antigen Recognition: From Fundamental Insights to Clinical Applications Johannes Huppa
Chairperson: Xing Chang
20:00-20:30 A Chimeric autoantibody receptor T cells to treat anti-cytokines autoantibodies Cheng-Lung Ku
20:30-21:00 Mechanistic Insights into Tumor Evasion: Interpreting Anti-Tumor Immunity from a Whole-Body Systems Perspective Qijing Li

Nov. 6th

Chairperson: Ping Wang
8:30-9:20 Keynote Lecture —— Tumor antigens from the non-coding genome Sebastian Amigorena
Session 4
Chairperson: Ng Lai Guan
9:20-9:50 Metabolic triggers for cancer evolution Ashok Venkitaraman
9:50-10:20 New insights from tumor-infiltrating lymphocyte analyses Yosuke Togashi
Break
Chairperson: Xindong Liu
10:20-10:35 Tongke  
10:35-11:05 CAR T- or NK-cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant Naoki Hosen
11:05-11:35 γδ-T cell exosomes-based cancer immunotherapy Wenwei Tu
11:35-12:05 Macrophages and cancer immunotherapy Jun Chen
Session 5
Chairperson: Sirui Li
13:30-14:00 Cholesterol esterification blockade boosts immunotherapy and reduces cancer relapse Guangchuan Wang
14:00-14:30 Rescuing dendritic cell interstitial motility sustains antitumor immunity cycle Ting Zhou
Break
Chairperson: Yan Li
14:30-15:00 Advancing Immunotherapy Strategies Against Brain Tumors Qi Xie
15:00-15:30 Engagement of CD300ld and ld-L controls immunosuppressive state transition of neutrophils in cancer Min Luo
15:30-15:40 Closing remarks Feilong Meng

Organizers

Center for Excellence in Molecular Cell Science, CAS(Shanghai Institute of Biochemistry and Cell Biology)
Cell Research
Westlake University
Changping Laboratory
Shanghai Academy of Natural Sciences(SANS)
Molecular Immunology Division, the Chinese Society of Biochemistry and Molecular Biology (CSBMB)
Chinese Society for Cell Biology(CSCB)

Contact information

Registration:Lu Cui  021-54922818   meeting@csbmb.org.cn
Support and Exhibition: SONG Juan  021-54921090   18917324171 

© Copyright 2025 Cell Research symposium Organizing Committee - All rights reserved.

Back to top